Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19
Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) being developed to treat infected, high-risk individuals with COVID-19 Exploring…
Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) being developed to treat infected, high-risk individuals with COVID-19 Exploring…
Companies aim to benefit a million people by democratizing access to impactful technology GURGAON, India--(BUSINESS…
COLOMBO, Sri Lanka & LONDON--(BUSINESS WIRE)--ZILLIONe, the internationally networked enterprise solutions provider, recently completed the…
Alameda Research agrees on significant investment into quant trading firm, Folkvang The investment will help…
Preclinical Data on Candidate Anti Malaria Agents Published in Cell Host & Microbe KENILWORTH, N.J.…
LONDON--(BUSINESS WIRE)--The Professional Triathletes Organisation today released the following letter sent to the Board of…
With 10 million installs for apps in this series, we are now offering the very…
GUANG’AN, China--(BUSINESS WIRE)--Located in Sichuan Province, Guang’an is a city next to Chongqing. Boasting an…
Acquisition extends global reach and adds emotional intelligence and game-based assessments to portfolio of pre-employment…
TAIPEI, Taiwan--(BUSINESS WIRE)--CyberLink Corp. (5203.TW), a pioneer in AI and facial recognition technologies, announced a…